Showing results (871-880 of 895) with videos related to
Sort By:
Pageof 90
Drugs in R&D|May 23, 2014
Pharmacokinetics of a prototype formulation of sublingual testosterone and a buspirone tablet, versus an advanced combination tablet of testosterone and buspirone in healthy premenopausal womenKim van Rooij, Leo de Leede, Henderik W Frijlink, et al.Drugs in R&D|May 17, 2014
Efficacy and safety of a lercanidipine/enalapril fixed-dose combination in hypertensive patients in PortugalJoão Maldonado, Telmo Pereira, Alfredo TavaresDrugs in R&D|February 18, 2015
mTOR: a potential therapeutic target in osteoarthritis?Bandna Pal, Helal Endisha, Yue Zhang, et al.Drugs in R&D|March 4, 2015
Efficacy of lifestyle changes in subjects with non-alcoholic liver steatosis and metabolic syndrome may be improved with an antioxidant nutraceutical: a controlled clinical studyGianpaolo Sorrentino, Paola Crispino, Daniela Coppola, et al.Drugs in R&D|March 10, 2015
Use of adjectives in abstracts when reporting results of randomized, controlled trials from industry and academiaM Soledad Cepeda, Jesse A Berlin, Susan C Glasser, et al.Drugs in R&D|April 12, 2015
Recombinant Activated Factor VII Significantly Reduces Transfusion Requirements in Cardiothoracic SurgeryHesham R Omar, Garrett Enten, Rachel Karlnoski, et al.Drugs in R&D|September 29, 2012
Quadrivalent human papillomavirus (HPV) types 6, 11, 16, 18 vaccine for the prevention of genital warts in males: profile report. demail@springer.comKarly P Garnock-Jones, Anna R GiulianoDrugs in R&D|October 19, 2012
Post-marketing surveillance of levofloxacin 0.5% ophthalmic solution for external ocular infectionsYoshiko Kanda, Tomoko Kayama, Shinji Okamoto, et al.Drugs in R&D|November 17, 2025
Bioequivalence of Two Perampanel Oral Suspension Formulations in Healthy Subjects: A Randomized Crossover StudyAya M AbdelMagid, Kamal A Badr, Mamdouh R RezkDrugs in R&D|October 31, 2025
Bioequivalence Study of Bedaquiline and Sirturo® in Healthy Chinese Subjects Under Fasting and Postprandial Conditions: A Randomized, Open-Label, Single-Dose, Crossover TrialYixuan Li, Yi Wu, Shufan Cai, et al.Pageof 90